BBP vs. IBRN ETF Comparison
Comparison of BioShares Biotechnology Products Fund (BBP) to iShares Neuroscience and Healthcare ETF (IBRN)
BBP
BioShares Biotechnology Products Fund
BBP Description
The BioShares Biotechnology Products Fund (BBP) seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index.
Grade (RS Rating)
Last Trade
$59.10
Average Daily Volume
643
Number of Holdings
*
60
* may have additional holdings in another (foreign) market
IBRN
iShares Neuroscience and Healthcare ETF
IBRN Description
iShares Neuroscience and Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. The fund invests in public equity markets of global region. It invests in stocks of companies operating across neurology biopharmaceuticals or neurological devices sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the NYSE FactSet Global Neuro Biopharma and MedTech Index, by using representative sampling technique. iShares Neuroscience and Healthcare ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$23.75
Average Daily Volume
577
Number of Holdings
*
46
* may have additional holdings in another (foreign) market
Performance
| Period | BBP | IBRN |
|---|---|---|
| 30 Days | 4.56% | 0.74% |
| 60 Days | 7.63% | -0.99% |
| 90 Days | 7.20% | -4.32% |
| 12 Months | 12.30% | -2.24% |
BBP Overweight 54 Positions Relative to IBRN
| Symbol | Grade | Weight | |
|---|---|---|---|
| ALNY | B | 2.46% | |
| MIRM | B | 1.98% | |
| IONS | B | 1.83% | |
| TVTX | B | 1.82% | |
| UTHR | A | 1.76% | |
| AXSM | B | 1.76% | |
| GILD | C | 1.73% | |
| INSM | B | 1.73% | |
| DAWN | D | 1.71% | |
| TGTX | B | 1.71% | |
| HRMY | B | 1.69% | |
| ASND | C | 1.69% | |
| AUPH | C | 1.68% | |
| AMGN | B | 1.68% | |
| HALO | A | 1.66% | |
| IRWD | F | 1.65% | |
| EXEL | B | 1.64% | |
| MDGL | B | 1.64% | |
| BPMC | A | 1.63% | |
| LEGN | D | 1.63% | |
| YMAB | D | 1.63% | |
| REGN | A | 1.63% | |
| ADMA | A | 1.62% | |
| LGND | B | 1.61% | |
| KRYS | B | 1.6% | |
| ARDX | C | 1.6% | |
| KNSA | D | 1.58% | |
| BMRN | C | 1.58% | |
| VRTX | B | 1.57% | |
| APLS | F | 1.56% | |
| INCY | B | 1.56% | |
| BCRX | B | 1.56% | |
| TBPH | F | 1.55% | |
| SWTX | C | 1.53% | |
| RARE | D | 1.53% | |
| IOVA | F | 1.52% | |
| LXRX | D | 1.52% | |
| DVAX | F | 1.51% | |
| PHAT | C | 1.51% | |
| AGIO | B | 1.49% | |
| SAGE | F | 1.48% | |
| FOLD | F | 1.48% | |
| GERN | B | 1.45% | |
| RYTM | B | 1.44% | |
| ZLAB | F | 1.42% | |
| BGNE | F | 1.4% | |
| BBIO | F | 1.39% | |
| IMCR | D | 1.36% | |
| NVAX | C | 1.36% | |
| CRSP | D | 1.35% | |
| BNTX | F | 1.34% | |
| MRNA | D | 1.33% | |
| ESPR | B | 1.27% | |
| TARS | C | 1.21% |
BBP Underweight 40 Positions Relative to IBRN
| Symbol | Grade | Weight | |
|---|---|---|---|
| ARGX | B | -4.65% | |
| DYN | B | -4.5% | |
| BHVN | D | -4.1% | |
| ALKS | C | -3.99% | |
| CERE | C | -3.97% | |
| AXNX | B | -3.95% | |
| XENE | D | -3.9% | |
| IART | C | -3.67% | |
| CPRX | C | -3.13% | |
| SUPN | F | -2.9% | |
| AVDL | F | -2.68% | |
| EWTX | C | -2.35% | |
| PRTA | F | -1.95% | |
| SAVA | F | -1.73% | |
| LBPH | B | -1.51% | |
| SRRK | F | -1.1% | |
| DNTH | B | -1.04% | |
| NMRA | C | -1.02% | |
| WVE | D | -0.99% | |
| PEPG | B | -0.87% | |
| AVXL | C | -0.72% | |
| VYGR | F | -0.72% | |
| ANNX | C | -0.71% | |
| ALEC | F | -0.7% | |
| VNDA | B | -0.66% | |
| AXGN | B | -0.61% | |
| NVRO | F | -0.59% | |
| LRMR | C | -0.56% | |
| TRDA | D | -0.53% | |
| ANRO | D | -0.48% | |
| SLDB | F | -0.36% | |
| ABEO | F | -0.33% | |
| KYTX | F | -0.29% | |
| CAPR | D | -0.28% | |
| CVRX | C | -0.26% | |
| ABOS | F | -0.21% | |
| NPCE | F | -0.2% | |
| ATHA | B | -0.19% | |
| AMLX | D | -0.18% | |
| VTGN | F | -0.17% |
BBP: Top Represented Industries & Keywords
IBRN: Top Represented Industries & Keywords
Industries:
Biotechnology
Medical Devices
Drug Manufacturers - Specialty & Generic
Drug Manufacturers - Major
Keywords:
Biopharmaceutical
Biotechnology
Neuroscience
Alzheimer's Disease
Biology
Medicine
Muscular Dystrophy
Pain
Schizophrenia
Dystrophy
Epilepsy
Life Sciences
Cancer
Chemical Compounds
Duchenne
Duchenne Muscular Dystrophy
Neurodegenerative Diseases
Rare Diseases
Amyotrophic Lateral Sclerosis
Clinical Development
Compare ETFs
